Combination therapy with a statin and niacin may provide optimal therapy for patients with combined hyperlipidemia and low levels of high-density lipoprotein (HDL) cholesterol. The authors assessed ...

AstraZeneca today announced the launch of a new clinical trial, SATURN, designed to measure the impact of CRESTOR™ (rosuvastatin) 40 mg and atorvastatin (Lipitor®) 80 mg on the progression of ...

Rosuvastatin is generic crestor 40 mg used to treat hereditary types of high cholesterol hypercholesterolemia: The heterozygous type inherited from one parent or the homozygous type inherited from ...

Data presented at this year’s AHA reinforces the established efficacy profile of CRESTOR (rosuvastatin) Treatment with CRESTOR (rosuvastatin) or atorvastatin for two years resulted in statistically ...

SAN FRANCISCO, CA—Statin-naïve patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) scheduled for early invasive procedures who receive high-dose rosuvastatin on admission have a ...

Kyoto, Japan, Monday 29 September 2003. New data presented at the XIIIth International Symposium on Atherosclerosis (ISA) show AstraZeneca's highly effective statin CRESTOR (rosuvastatin) achieves ...

Government of Newfoundland and Labrador. Strength This refers to the amount of the active medicinal ingredient e. Benefit Status Open - Drugs which are reimbursed with no criteria or prior approval.

A 76-year-old Filipina woman who had been taking rosuvastatin 40 mg per day without a problem for more than 5 years started developing pain and weakness in her thighs just days after starting on the ...

The treatment groups were well matched demographically ( Table I). A total of 270 patients (of 774 recruited) were randomized as follows: rosuvastatin monotherapy (n=46), ER niacin monotherapy (n=72), ...

LONDON, January 15 /PRNewswire/ -- AstraZeneca (LSE: AZN) (NYSE: AZN) today announced the launch of a new clinical trial, SATURN, designed to measure the impact of CRESTOR(TM) (rosuvastatin) 40 mg and ...